Vascular disease treatments are more effective when the root cause is diagnosed. The diagnosis of vascular conditions often requires a series of tests to determine the nature and extent of the problem. The doctors at Baton Rouge Vascular Specialty Center can help identify underlying issues, as well as the severity of your condition. Common vascular conditions Peripheral artery disease (PAD) PAD is a circulatory condition in which narrowed blood vessels reduce the flow of blood to your extremities. Carotid occlusive disease This disease causes a narrowing of the blood vessels in the neck. These blood vessels are responsible for carrying
Read More
Archives for Uncategorized
Local surgeon does breakthrough procedure for aortic aneurysm
Meet Dr. Vince Weaver, a highly skilled vascular surgeon with the Vascular Specialty Center here in Baton Rouge. On “A.M. BATON ROUGE” with Kevin & Bill, the good doctor details a relatively new procedure for repairing an aneurysm of the aorta, the body’s largest artery. Here him talk about it by clicking here.
Read More
Dr. Joseph Griffin was featured on Channel 9 – WAFB’s morning show.
Baton Rouge Vascular Specialty Center’s Dr. Joseph Griffin was featured on WAFB’s morning show to discuss heart healthy lifestyle tips as well as the warning signs of vascular and cardiac issues.
Read More
Don’t Take a Chance with Your Health: Attend Our Free Peripheral Artery Disease Screening on March 20th!
Peripheral arterial disease (PAD) is when large and medium-sized peripheral arteries — which supply blood to the head, organs and limbs — become narrow or clogged and restrict blood flow. PAD is dangerous and potentially deadly. Most often found in the legs, PAD is caused by the buildup of plaque (atherosclerosis). It can cause pain, disability, organ failure and other serious consequences to lifestyle and health — even death. Also, atherosclerosis in the peripheral arteries is often accompanied by the same problem in the coronary arteries, which is heart disease. If you’re at risk, get screened for PAD! PAD on
Read More
Peripheral Artery Disease Can Be a Silent Killer. Attend Our Free Screening on Feb. 6 to Learn if You Are at Risk.
Peripheral arterial disease (PAD) is when large and medium-sized peripheral arteries — which supply blood to the head, organs and limbs — become narrow or clogged and restrict blood flow. PAD is dangerous and potentially deadly. Most often found in the legs, PAD is caused by the buildup of plaque (atherosclerosis). It can cause pain, disability, organ failure and other serious consequences to lifestyle and health — even death. Also, atherosclerosis in the peripheral arteries is often accompanied by the same problem in the coronary arteries, which is heart disease. If you’re at risk, get screened for PAD! PAD on
Read More
Peripheral Artery Disease Can Be a Silent Killer. Attend Our Free Screening on Jan. 16 to Learn if You Are at Risk.
Peripheral arterial disease (PAD) is when large and medium-sized peripheral arteries — which supply blood to the head, organs and limbs — become narrow or clogged and restrict blood flow. PAD is dangerous and potentially deadly. Most often found in the legs, PAD is caused by the buildup of plaque (atherosclerosis). It can cause pain, disability, organ failure and other serious consequences to lifestyle and health — even death. Also, atherosclerosis in the peripheral arteries is often accompanied by the same problem in the coronary arteries, which is heart disease. If you’re at risk, get screened for PAD! PAD on
Read More
Vascular Specialty Center Physician to Report Experience with Minimally-Invasive Laparoscopic Aortic Reconstruction
Dr. Andrew J. Olinde will discuss Vascular Specialty Center results of laparoscopic aortic repair at the 31st annual Northwestern Vascular Symposium on December 14th, 2006 in Chicago, IL. This meeting represents a major international forum for the specialty of vascular surgery and endovascular therapy. In conjunction with addressing the attendants, Vascular Specialty Center physicians will contribute a chapter for the accompanying textbook for the meeting – Trends in Vascular Surgery. Vascular Specialty Center is the leading center for laparoscopic aortic surgery in the United States having performed over 50 cases. “We are honored to have been invited to present our
Read More
Vascular Specialty Center and Neuromedical Center Collaborate For Stroke-Prevention Clinical Trial
Baton Rouge, LA – Vascular Specialty Center is pleased to announce their collaboration with the Neuromedical Center for enrollment into the CREST trial for stroke prevention. The only carotid stenting stroke prevention trial sponsored by the National Institutes of Health, Vascular Specialty Center ranks as a leading enrolling site for this landmark, multicenter clinical trial. “We wish to sincerely thank the neurologists and staff of the fine Neuromedical Center for joining with us in delivering the latest vascular technologies to the people of South Louisiana”, says Dr. Andrew Olinde, Vascular Specialty Center physician.
Read More
Vascular Specialty Center Selected to Assess Effectiveness of New Vascular Graft
Baton Rouge, LA – Vascular Specialty Center physicians in conjunction with Vascular Specialty Center Clinical Research division has been selected as one of a few national sites to assess the efficacy of a new vascular graft. The GORE PROPATEN Vascular Graft is the first ePTFE vascular graft that reduces clotting and is designed to address the clinical problem of thrombotic vascular graft failure. The GORE PROPATEN Vascular Graft is the first and only ePTFE-heparin combination in an emerging class of medical products that combine mechanical and biological elements. It is designed to address the gap in clinical performance between synthetic
Read More
Vascular Specialty Center Physician Co-authors Results of Leading Vascular Clinical Trial Results Zymo trial
Baton Rouge, LA – A Vascular Specialty Center physician has recently co-authored results of a Phase 3 multiple site, randomized, double-blind, controlled trial designed to evaluate the comparative efficacy and safety of rhThrombin and bovine thrombin in patients undergoing spinal surgery, hepatic resection, peripheral arterial bypass surgery, or arteriovenous graft formation for hemodialysis access (Journal of the American College of Surgeons 2007 Aug; 205(2):256-65.). Results of this trial suggest that rhThrombin has comparable efficacy, a similar safety profile, and is considerably less immunogenic than bovine thrombin when used for surgical hemostasis. “As a principle investigator and leading enroller for the
Read More